➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
Express Scripts
Johnson and Johnson
Mallinckrodt

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

RETET Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Retet, and when can generic versions of Retet launch?

Retet is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in RETET is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Summary for RETET
Drug patent expirations by year for RETET
Synonyms for RETET
(-)-Tetrahcycline hydrochloride
(4S,4aS,5aS,6S,12aS,Z)-2-(amino(hydroxy)methylene)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione hydrochloride
(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
(4S,6S,12aS,4aS,5aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,1 1-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, chloride
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12alpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha)]-
4-(dimethy lamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, mono-hydrochloride
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, mono-hydrochloride
64-75-5
AB1009394
Achro
Achromycin
Achromycin hydrochloride
Actisite
AI3-50120
AKOS015951263
ALA TET
Ambracyn
Artomycin
artromycin
BCP0726000161
BCP9000227
Bristacycline
Bristacycline (TN)
C22H24N2O8.HCl
Cancycline-250
CAS-64-75-5
CCG-39267
CCRIS 2351
Cefracycline tablets
CHEMBL1562925
CHEMBL454950
Chlorhydrate de tetracycline
Chlorhydrate de tetracycline [French]
Chlorowodorku tetracykliny
Chlorowodorku tetracykliny [Polish]
CS-2588
D02122
Democra cin
Diacycine
Diacycline
DSSTox_CID_1321
DSSTox_GSID_21321
DSSTox_RID_76081
DTXSID6021321
Dumocyclin
EBD2198184
EC 200-593-8
EINECS 200-593-8
fermentmycin
Helvecyclin
HMS1568K22
HMS1921C19
Hostacycline
HY-B0474
Imex
K044
KS-1431
LS-63
MCULE-8111555447
Mephacyclin
MFCD00078142
Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, mo nohydrachloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))
Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrachloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))
NCGC00016291-01
NCGC00017323-08
NCGC00094790-01
NCGC00094790-02
NCGC00180907-01
NCGC00180907-02
NCGC00258070-01
NCI-C55561
NCI-c55561;Tetracycline HCl
Neocyclin B
NSC-757338
NSC757338
P6R62377KV
Paltet
Panmycin hydrochloride
Partrex
Pharmakon1600-01500566
Piracaps
Polycycline hydrochloride
Polyotic ointment
Prestwick_434
Q27286287
Qidtet
Quadracycline
Quatrex
Remicyclin
Ricycline
Ro-Cycline
s2574
Sanclomy cine
Sanclomycine
SBB006497
SC-19458
SCHEMBL34248
Sentry av ornacycline
SPECTRUM1500566
SR-01000000212
SR-01000000212-4
SR-05000001723
SR-05000001723-2
ST057166
ST24050122
Steclin
Steclin hydrochloride
Stilciclina
Subamycin
Supramycin
Supramycine
Sustamycin
SW196293-4
T-250 Capsules
Tefilin
Teline
Telotrex
Tet-cy
Tetra-D
Tetra-wedel
Tetrabakat
Tetrabid
Tetrablet
Tetracaps
Tetraciclina cloridrato
Tetraciclina cloridrato [Italian]
Tetracompren
Tetracycline (hydrochloride)
Tetracycline chloride
Tetracycline HCl
TETRACYCLINE HYDROCHLORIDE
Tetracycline hydrochloride (internal use)
Tetracycline hydrochloride (JP17/USP)
Tetracycline hydrochloride [USAN:JAN]
Tetracycline hydrochloride [USP:JAN]
Tetracycline hydrochloride, 'can be used as secondary standard'
Tetracycline hydrochloride, [can be used as secondary standard]
Tetracycline hydrochloride, >=95% (European Pharmacopoeia HPLC assay)
Tetracycline hydrochloride, British Pharmacopoeia (BP) Reference Standard
Tetracycline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tetracycline hydrochloride, meets USP testing specifications
Tetracycline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Tetracycline hydrochloride, powder
Tetracycline hydrochloride, powder, BioReagent, suitable for cell culture
Tetracycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tetracycline hydrochloride, VETRANAL(TM), analytical standard
tetracycline-hydrochloride
Tetracycline.HCl
Tetracyclinehydrochloride
Tetracyn hydrochloride
Tetrakap
Tetralution
Tetramavan
Tetramed
TetraSURE
Tetrosol
Topicycline
Totomyc in
Tox21_110355
Tox21_110355_1
Tox21_200516
Triphacyclin
U-5965
Unicin
UNII-P6R62377KV
Vetquamycin-324
YCIHPQHVWDULOY-PNYJHNNPSA-N

US Patents and Regulatory Information for RETET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay RETET tetracycline hydrochloride CAPSULE;ORAL 061443-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay RETET tetracycline hydrochloride CAPSULE;ORAL 061443-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
Express Scripts
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.